These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12107853)

  • 1. Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?
    Eschweiler GW; Bartels M; Längle G; Wild B; Gaertner I; Nickola M
    Pharmacopsychiatry; 2002 May; 35(3):96-100. PubMed ID: 12107853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of olanzapine and clozapine upon pulse rate variability.
    Mueck-Weymann M; Rechlin T; Ehrengut F; Rauh R; Acker J; Dittmann RW; Czekalla J; Joraschky P; Musselman D
    Depress Anxiety; 2002; 16(3):93-9. PubMed ID: 12415532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine.
    Agelink MW; Majewski T; Wurthmann C; Lukas K; Ullrich H; Linka T; Klieser E
    J Clin Psychopharmacol; 2001 Feb; 21(1):8-13. PubMed ID: 11199953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine.
    Alfaro CL; Wudarsky M; Nicolson R; Gochman P; Sporn A; Lenane M; Rapoport JL
    J Child Adolesc Psychopharmacol; 2002; 12(2):83-91. PubMed ID: 12188977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of high-dose olanzapine in a double-blind crossover study.
    Kelly DL; Richardson CM; Yu Y; Conley RR
    Hum Psychopharmacol; 2006 Aug; 21(6):393-8. PubMed ID: 16850522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between plasma clozapine concentration and heart rate variability in schizophrenic patients.
    Rechlin T; Beck G; Weis M; Kaschka WP
    Psychopharmacology (Berl); 1998 Feb; 135(4):338-41. PubMed ID: 9539257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia.
    Schuld A; Kühn M; Haack M; Kraus T; Hinze-Selch D; Lechner C; Pollmächer T
    Pharmacopsychiatry; 2000 May; 33(3):109-11. PubMed ID: 10855462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder.
    Spina E; D'Arrigo C; Migliardi G; Santoro V; Muscatello MR; Micò U; D'Amico G; Perucca E
    Ther Drug Monit; 2006 Oct; 28(5):599-602. PubMed ID: 17038872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart rate variability in schizophrenic patients treated with antipsychotic agents].
    Cohen H; Loewenthal U; Matar M; Kotler M
    Harefuah; 2001 Dec; 140(12):1142-7, 1231. PubMed ID: 11789296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of heart rate variability (HRV) for monitoring clozapine plasma levels.
    Agelink MW; Sayar K; Klieser E
    Pharmacopsychiatry; 2003 Jul; 36(4):166-7; authors reply 168. PubMed ID: 12905104
    [No Abstract]   [Full Text] [Related]  

  • 14. Autonomic responses of blood vessels and sweat glands in patients with schizophrenia treated with olanzapine or clozapine.
    Mueck-Weymann M; Acker J; Agelink MW
    Psychopharmacology (Berl); 2001 Oct; 157(4):368-72. PubMed ID: 11605095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.
    Bitter I; Dossenbach MR; Brook S; Feldman PD; Metcalfe S; Gagiano CA; Füredi J; Bartko G; Janka Z; Banki CM; Kovacs G; Breier A;
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):173-80. PubMed ID: 14687871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses.
    Melkersson KI; Dahl ML
    Psychopharmacology (Berl); 2003 Nov; 170(2):157-66. PubMed ID: 12851739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine augmentation of clozapine.
    Gupta S; Sonnenberg SJ; Frank B
    Ann Clin Psychiatry; 1998 Sep; 10(3):113-5. PubMed ID: 9781474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography.
    Weigmann H; Härtter S; Maehrlein S; Kiefer W; Krämer G; Dannhardt G; Hiemke C
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 759(1):63-71. PubMed ID: 11499630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of psychopharmacologic therapy on heart rate variation].
    Rechlin T
    Nervenarzt; 1995 Sep; 66(9):678-85. PubMed ID: 7477605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of pathologic cardiac parameters after transition from clozapine to olanzapine treatment: a case report.
    Cohen H; Loewenthal U; Matar MA; Kotler M
    Clin Neuropharmacol; 2001; 24(2):106-8. PubMed ID: 11307047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.